| Who is it? | Actor |
| Birth Day | April 01, 1958 |
| Birth Place | American |
| Age | 65 YEARS OLD |
| Alma mater | Stanford University, Cornell University |
| Known for | Discovering how proteins cause cell membranes to fuse, and pioneering efforts to develop an HIV vaccine based on inhibiting membrane fusion. |
| Institutions | Merck & Co., Inc. |
| Website | Peter S. Kim Lab at Stanford |
Peter Y. Kim, a prominent actor based in America, is expected to have a net worth ranging from $100,000 to $1 million in the year 2024. Known for his exceptional talent and versatile acting skills, Peter Y. Kim has made a significant impact in the entertainment industry. With numerous notable roles in both film and television, he has gained a loyal fanbase and critical acclaim. As he continues to establish himself as a prominent figure in the acting world, Peter Y. Kim's net worth is projected to grow substantially in the coming years.
Kim is of Korean descent. Kim grew up in Ridgewood, New Jersey the son of a single mother, and his first job was in 1974 at a Roy Rogers restaurant, where he earned money to pay for college. Kim earned his A.B. in chemistry at Cornell University in 1979 and trained as a Ph.D. in Biochemistry at Stanford University under the guidance of Robert Baldwin. While at Stanford, he was also a Medical Scientist Training Program Fellow.
During his tenure, Merck gained approval of more than 20 new medicines and vaccines. These include Januvia (the first DPP-4 inhibitor for type 2 diabetes), Gardasil (the first vaccine for prevention of cervical cancer), Isentress (the first HIV integrase inhibitor), Zostavax (the first vaccine for the prevention of shingles in adults), Rotateq (an oral vaccine for the prevention of rotavirus infection in infants), and Victrelis (the first hepatitis C protease inhibitor). In 2013, he retired from Merck and was succeeded by Roger Perlmutter
